Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

Published:2021-11-15 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Legg Lynn A¹,Rudberg Ann-Sofie²,Hua Xing³,Wu Simiao³,Hackett Maree L⁴,Tilney Russel⁵,Lindgren Linnea⁶,Kutlubaev Mansur A⁷,Hsieh Cheng-Fang⁸,Barugh Amanda J⁹,Hankey Graeme J¹⁰,Lundström Erik⁶,Dennis Martin¹¹,Mead Gillian E¹¹

Affiliation:

1. NHS Greater Glasgow and Clyde Health Board; Paisley UK

2. Division of Neurology, Department of Clinical Sciences; Karolinska Institutet Danderyd Hospital; Stockholm Sweden

3. Department of Neurology; West China Hospital, Sichuan University; Chengdu China

4. Professor, Program Head, Mental Health; The George Institute for Global Health, Faculty of Medicine, University of New South Wales; Sydney Australia

5. Department of Medicine; Mater Dei Hospital; Msida Malta

6. Department of Neuroscience, Neurology; Uppsala University; Uppsala Sweden

7. Department of Neurology, Neurosurgery and Medical Genetics; Bashkir State Medical University; Ufa Russian Federation

8. Division of Geriatrics and Gerontology, Department of Internal Medicine and Department of Neurology, Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan

9. Department of Geriatric Medicine; University of Edinburgh; Edinburgh UK

10. Medical School, Faculty of Health and Medical Sciences,; The University of Western Australia; Perth Australia

11. Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference219 articles.

1. Serotonergic modulation of brain excitability and motor recovery in patients affected by stroke. A double blind placebo RCT;Acler;International Journal of Stroke,2008

2. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients;Acler;Journal of Neurology,2009

3. Assessment of fluoxetine in stroke recovery (AFFINITY) trial, 2011 www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000774921

4. The assessment of fluoxetine in stroke recovery imaging and blood biomarkers sub-study AFFINITY BM www.anzctr.org.au/Trial/Registration/TrialReview.aspx ?ACTRN=12619000986178

5. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial;AFFINITY Trial Collaboration;Lancet Neurology,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke Alters the Function of Enteric Neurons to Impair Smooth Muscle Relaxation and Dysregulates Gut Transit;Journal of the American Heart Association;2024-01-23

2. Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases;JAMA Psychiatry;2023-12-01

3. Stroke Recovery Is a Journey: Prediction and Potentials of Motor Recovery after a Stroke from a Practical Perspective;Life;2023-10-15

4. Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression;Molecular Neurobiology;2023-08-17

5. Astrocytes in Post-Stroke Depression: Roles in Inflammation, Neurotransmission, and Neurotrophin Signaling;Cellular and Molecular Neurobiology;2023-07-20